In vivo phenotypic characteristics of AKR T-cell lymphomas with different leukemic potential: Possible role of α4β7 integrin in the progression towards the leukemic phenotype

R. Dolcetti, T. Frisan, G. Palmieri, S. Rizzo, R. Maestro, A. Santoni, M. Boiocchi

Research output: Contribution to journalArticle

Abstract

The present study was undertaken in order to determine whether the expression of specific surface molecules which mediate immune recognition as well as cell-cell and cell-matrix interactions is associated with the leukemic evolution of T-cell lymphomas. To this end, we have investigated the in vivo phenotypic characteristics and the in vitro natural-killer(NK)-cell susceptibility of a group of MCF-247-induced AKR/J T-cell lymphomas with different leukemic potential. We found that in the AKR/J model, the biological aggressiveness of leukemic cells is not dependent upon an escape from host immune surveillance as a consequence of an in vivo down-regulation of H2-K(k) determinants or a resistance to NK lysis. Moreover, NK susceptibility of AKR/J lymphomas does not seem to correlate with the level of H2-antigen expression. No obvious correlation was found between the leukemic phenotype and the amount of MEL-14, LFA-I, ICAM-I, Pgp-I/CD44 and THAM/CD26 antigen expression. An in vivo coordinated up-regulation of α4 and β7 integrin chains, with the highest levels of expression detected in secondary sites of leukemic infiltration, was observed in the highly leukemic lymphoma NQ22 and, albeit to a lesser extent, in lymphomas with moderate leukemic potential. Conversely, non-leukemic lymphomas were repeatedly α4- and β7-negative. These findings suggest that in the AKR/J system the expression of α4 β7 integrin may contribute to leukemic spreading of T- cell lymphomas.

Original languageEnglish
Pages (from-to)560-567
Number of pages8
JournalInternational Journal of Cancer
Volume56
Issue number4
Publication statusPublished - 1994

Fingerprint

T-Cell Lymphoma
Integrins
Lymphoma
Phenotype
Leukemic Infiltration
H-2 Antigens
Dipeptidyl Peptidase 4
Biological Models
Innate Immunity
Cell Communication
Natural Killer Cells
Up-Regulation
Down-Regulation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

In vivo phenotypic characteristics of AKR T-cell lymphomas with different leukemic potential : Possible role of α4β7 integrin in the progression towards the leukemic phenotype. / Dolcetti, R.; Frisan, T.; Palmieri, G.; Rizzo, S.; Maestro, R.; Santoni, A.; Boiocchi, M.

In: International Journal of Cancer, Vol. 56, No. 4, 1994, p. 560-567.

Research output: Contribution to journalArticle

@article{4c36fbac633049b9be107d5cf2d94553,
title = "In vivo phenotypic characteristics of AKR T-cell lymphomas with different leukemic potential: Possible role of α4β7 integrin in the progression towards the leukemic phenotype",
abstract = "The present study was undertaken in order to determine whether the expression of specific surface molecules which mediate immune recognition as well as cell-cell and cell-matrix interactions is associated with the leukemic evolution of T-cell lymphomas. To this end, we have investigated the in vivo phenotypic characteristics and the in vitro natural-killer(NK)-cell susceptibility of a group of MCF-247-induced AKR/J T-cell lymphomas with different leukemic potential. We found that in the AKR/J model, the biological aggressiveness of leukemic cells is not dependent upon an escape from host immune surveillance as a consequence of an in vivo down-regulation of H2-K(k) determinants or a resistance to NK lysis. Moreover, NK susceptibility of AKR/J lymphomas does not seem to correlate with the level of H2-antigen expression. No obvious correlation was found between the leukemic phenotype and the amount of MEL-14, LFA-I, ICAM-I, Pgp-I/CD44 and THAM/CD26 antigen expression. An in vivo coordinated up-regulation of α4 and β7 integrin chains, with the highest levels of expression detected in secondary sites of leukemic infiltration, was observed in the highly leukemic lymphoma NQ22 and, albeit to a lesser extent, in lymphomas with moderate leukemic potential. Conversely, non-leukemic lymphomas were repeatedly α4- and β7-negative. These findings suggest that in the AKR/J system the expression of α4 β7 integrin may contribute to leukemic spreading of T- cell lymphomas.",
author = "R. Dolcetti and T. Frisan and G. Palmieri and S. Rizzo and R. Maestro and A. Santoni and M. Boiocchi",
year = "1994",
language = "English",
volume = "56",
pages = "560--567",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - In vivo phenotypic characteristics of AKR T-cell lymphomas with different leukemic potential

T2 - Possible role of α4β7 integrin in the progression towards the leukemic phenotype

AU - Dolcetti, R.

AU - Frisan, T.

AU - Palmieri, G.

AU - Rizzo, S.

AU - Maestro, R.

AU - Santoni, A.

AU - Boiocchi, M.

PY - 1994

Y1 - 1994

N2 - The present study was undertaken in order to determine whether the expression of specific surface molecules which mediate immune recognition as well as cell-cell and cell-matrix interactions is associated with the leukemic evolution of T-cell lymphomas. To this end, we have investigated the in vivo phenotypic characteristics and the in vitro natural-killer(NK)-cell susceptibility of a group of MCF-247-induced AKR/J T-cell lymphomas with different leukemic potential. We found that in the AKR/J model, the biological aggressiveness of leukemic cells is not dependent upon an escape from host immune surveillance as a consequence of an in vivo down-regulation of H2-K(k) determinants or a resistance to NK lysis. Moreover, NK susceptibility of AKR/J lymphomas does not seem to correlate with the level of H2-antigen expression. No obvious correlation was found between the leukemic phenotype and the amount of MEL-14, LFA-I, ICAM-I, Pgp-I/CD44 and THAM/CD26 antigen expression. An in vivo coordinated up-regulation of α4 and β7 integrin chains, with the highest levels of expression detected in secondary sites of leukemic infiltration, was observed in the highly leukemic lymphoma NQ22 and, albeit to a lesser extent, in lymphomas with moderate leukemic potential. Conversely, non-leukemic lymphomas were repeatedly α4- and β7-negative. These findings suggest that in the AKR/J system the expression of α4 β7 integrin may contribute to leukemic spreading of T- cell lymphomas.

AB - The present study was undertaken in order to determine whether the expression of specific surface molecules which mediate immune recognition as well as cell-cell and cell-matrix interactions is associated with the leukemic evolution of T-cell lymphomas. To this end, we have investigated the in vivo phenotypic characteristics and the in vitro natural-killer(NK)-cell susceptibility of a group of MCF-247-induced AKR/J T-cell lymphomas with different leukemic potential. We found that in the AKR/J model, the biological aggressiveness of leukemic cells is not dependent upon an escape from host immune surveillance as a consequence of an in vivo down-regulation of H2-K(k) determinants or a resistance to NK lysis. Moreover, NK susceptibility of AKR/J lymphomas does not seem to correlate with the level of H2-antigen expression. No obvious correlation was found between the leukemic phenotype and the amount of MEL-14, LFA-I, ICAM-I, Pgp-I/CD44 and THAM/CD26 antigen expression. An in vivo coordinated up-regulation of α4 and β7 integrin chains, with the highest levels of expression detected in secondary sites of leukemic infiltration, was observed in the highly leukemic lymphoma NQ22 and, albeit to a lesser extent, in lymphomas with moderate leukemic potential. Conversely, non-leukemic lymphomas were repeatedly α4- and β7-negative. These findings suggest that in the AKR/J system the expression of α4 β7 integrin may contribute to leukemic spreading of T- cell lymphomas.

UR - http://www.scopus.com/inward/record.url?scp=0028299206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028299206&partnerID=8YFLogxK

M3 - Article

C2 - 8112892

AN - SCOPUS:0028299206

VL - 56

SP - 560

EP - 567

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -